Concepedia

Sheri McMahon

SM

13

Publications

591

Citations

12

H-Index

1984

Active since

Affiliations

National Cancer Institute(Current)

National Institutes of Health

Center for Cancer Research

Office of the Director

Rutgers, The State University of New Jersey

Sheri McMahon is an author at National Cancer Institute specializing in medicine, immunotherapy, and pharmacotherapy.

Top concepts

Publications per year

1984–2023

13

Publications

13

First-in-Human Phase I Trial of a Tumor-Targeted Cytokine (NHS-IL12) in Subjects with Metastatic Solid Tumors

Julius Strauss, Christopher R. Heery, Joseph W. Kim et al. · Clinical Cancer Research · 2018 · 164 citations · Full text

Docetaxel Alone or in Combination With a Therapeutic Cancer Vaccine (PANVAC) in Patients With Metastatic Breast Cancer

Christopher R. Heery, Nuhad K. Ibrahim, Philip M. Arlen et al. · JAMA Oncology · 2015 · 99 citations · Full text

Phase I Study of a Poxviral TRICOM-Based Vaccine Directed Against the Transcription Factor Brachyury

Christopher R. Heery, Claudia Palena, Sheri McMahon et al. · Clinical Cancer Research · 2017 · 65 citations · Full text

A Phase I Trial Using a Multitargeted Recombinant Adenovirus 5 (CEA/MUC1/Brachyury)-Based Immunotherapy Vaccine Regimen in Patients with Advanced Cancer

Margaret E. Gatti‐Mays, Jason M. Redman, Renee N. Donahue et al. · The Oncologist · 2019 · 59 citations · Full text

Phase I study of a multitargeted recombinant Ad5 PSA/MUC-1/brachyury-based immunotherapy vaccine in patients with metastatic castration-resistant prostate cancer (mCRPC)

Marijo Bilušić, Sheri McMahon, Ravi A. Madan et al. · Journal for ImmunoTherapy of Cancer · 2021 · 59 citations · Full text

Rows per page

1–5 of 13